93 related articles for article (PubMed ID: 8164837)
1. Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism.
Schneider JS; DiStefano L
Neurology; 1994 Apr; 44(4):748-50. PubMed ID: 8164837
[TBL] [Abstract][Full Text] [Related]
2. LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment.
Schneider JS; DiStefano L
Neuroreport; 1993 Nov; 5(2):103-4. PubMed ID: 8110995
[TBL] [Abstract][Full Text] [Related]
3. Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion.
Schneider JS; Distefano L
Neuropharmacology; 1995 May; 34(5):489-93. PubMed ID: 7566482
[TBL] [Abstract][Full Text] [Related]
4. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L
Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379
[TBL] [Abstract][Full Text] [Related]
5. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism.
Schneider JS; Yuwiler A
Exp Neurol; 1989 Aug; 105(2):177-83. PubMed ID: 2568945
[TBL] [Abstract][Full Text] [Related]
6. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
Hadjiconstantinou M; Mariani AP; Neff NH
Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
[TBL] [Abstract][Full Text] [Related]
7. Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Schneider JS
Neuropharmacology; 1992 Feb; 31(2):185-92. PubMed ID: 1553028
[TBL] [Abstract][Full Text] [Related]
8. GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice.
Fazzini E; Durso R; Davoudi H; Szabo GK; Albert ML
J Neurol Sci; 1990 Oct; 99(1):59-68. PubMed ID: 2250172
[TBL] [Abstract][Full Text] [Related]
9. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
Schneider JS
J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
[TBL] [Abstract][Full Text] [Related]
10. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
[TBL] [Abstract][Full Text] [Related]
11. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
Hadjiconstantinou M; Neff NH
J Neurochem; 1988 Oct; 51(4):1190-6. PubMed ID: 3262149
[TBL] [Abstract][Full Text] [Related]
12. [Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
Kucherianu VG; Kryzhanovskiĭ GN; Kudrin VS; Iurasov VV; Nikushkin EV; Zhigal'tsev IV
Biull Eksp Biol Med; 1999 May; 127(5):502-5. PubMed ID: 10399565
[No Abstract] [Full Text] [Related]
13. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
Date I; Asari S; Nishimoto A; Felten DL
No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347
[TBL] [Abstract][Full Text] [Related]
14. Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.
Rothblat DS; Schneider JS
Ann N Y Acad Sci; 1998 Jun; 845():274-7. PubMed ID: 9668361
[TBL] [Abstract][Full Text] [Related]
15. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
Mayer RA; Walters AS; Heikkila RE
Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions.
Elsworth JD; Deutch AY; Redmond DE; Taylor JR; Sladek JR; Roth RH
Neuroscience; 1989; 33(2):323-31. PubMed ID: 2622529
[TBL] [Abstract][Full Text] [Related]
17. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl.
Saitoh T
J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627
[TBL] [Abstract][Full Text] [Related]
18. Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP.
Hadjiconstantinou M; Rossetti ZL; Paxton RC; Neff NH
Neuropharmacology; 1986 Sep; 25(9):1075-7. PubMed ID: 3490632
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the neurotoxic potential of m-methoxy-MPTP and the use of its N-ethyl analogue as a means of avoiding exposure to a possible Parkinsonism-causing agent.
Zimmerman DM; Cantrell BE; Reel JK; Hemrick-Luecke SK; Fuller RW
J Med Chem; 1986 Aug; 29(8):1517-20. PubMed ID: 3488406
[TBL] [Abstract][Full Text] [Related]
20. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.
Date I; Felten SY; Felten DL
Neurosci Lett; 1989 Dec; 106(3):282-6. PubMed ID: 2601883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
